{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:34:06Z","timestamp":1778571246722,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91776352"],"award-info":[{"award-number":["91776352"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1072-x","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T06:41:32Z","timestamp":1526452892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Parkinson\u2019s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-041X","authenticated-orcid":false,"given":"Anouke","family":"van Rumund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein B.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianne A. J.","family":"Esselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick J. A.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"1072_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"AJ Hughes","year":"2002","unstructured":"Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861\u201370.","journal-title":"Brain"},{"key":"1072_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1072_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1\u20139.","journal-title":"Neurology"},{"key":"1072_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","volume":"54","author":"I Litvan","year":"1997","unstructured":"Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997;54:937\u201344.","journal-title":"Arch Neurol"},{"key":"1072_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mds.25327","volume":"28","author":"G Respondek","year":"2013","unstructured":"Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, et al. Accuracy of the National Institute for neurological disorders and stroke\/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord. 2013;28:504\u20139.","journal-title":"Mov Disord"},{"key":"1072_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00415-011-6280-x","volume":"259","author":"FJ Meijer","year":"2012","unstructured":"Meijer FJ, Aerts MB, Abdo WF, Prokop M, Borm GF, Esselink RA, et al. Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study. J Neurol. 2012;259:929\u201335.","journal-title":"J Neurol"},{"key":"1072_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","volume":"80","author":"CJ Cochrane","year":"2013","unstructured":"Cochrane CJ, Ebmeier KP. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology. 2013;80:857\u201364.","journal-title":"Neurology"},{"key":"1072_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1148\/rg.345140009","volume":"34","author":"SM Broski","year":"2014","unstructured":"Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics. 2014;34:1273\u201392.","journal-title":"Radiographics"},{"key":"1072_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0034-1381733","volume":"34","author":"F Holtbernd","year":"2014","unstructured":"Holtbernd F, Eidelberg D. The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes. Semin Neurol. 2014;34:202\u20139.","journal-title":"Semin Neurol"},{"key":"1072_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2013.06.032","volume":"332","author":"FJ Meijer","year":"2013","unstructured":"Meijer FJ, Bloem BR, Mahlknecht P, Seppi K, Goraj B. Update on diffusion MRI in Parkinson's disease and atypical parkinsonism. J Neurol Sci. 2013;332:21\u20139.","journal-title":"J Neurol Sci"},{"key":"1072_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112638","volume":"9","author":"A Worker","year":"2014","unstructured":"Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, et al. Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One. 2014;9:e112638.","journal-title":"PLoS One"},{"key":"1072_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H. Iron metabolism in parkinsonian syndromes. Mov Disord. 2006;21:1299\u2013310.","journal-title":"Mov Disord"},{"key":"1072_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cortex.2015.08.005","volume":"73","author":"M Tahmasian","year":"2015","unstructured":"Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, et al. A systematic review on the applications of resting-state fMRI in Parkinson's disease: does dopamine replacement therapy play a role? Cortex. 2015;73:80\u2013105.","journal-title":"Cortex"},{"key":"1072_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","volume":"28","author":"WF Abdo","year":"2007","unstructured":"Abdo WF, Bloem BR, Van Geel WJ, Esselink RA, Verbeek MM. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease. Neurobiol Aging. 2007;28:742\u20137.","journal-title":"Neurobiol Aging"},{"key":"1072_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/mds.10714","volume":"19","author":"WF Abdo","year":"2004","unstructured":"Abdo WF, De Jong D, Hendriks JC, Horstink MW, Kremer BP, Bloem BR, et al. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease. Mov Disord. 2004;19:571\u20139.","journal-title":"Mov Disord"},{"key":"1072_CR16","doi-asserted-by":"publisher","first-page":"430 e1","DOI":"10.1016\/j.neurobiolaging.2010.12.001","volume":"33","author":"MB Aerts","year":"2012","unstructured":"Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM. CSF alpha-synuclein does not differentiate between parkinsonian disorders. Neurobiol Aging. 2012;33:430 e1\u20133.","journal-title":"Neurobiol Aging"},{"key":"1072_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.10687","volume":"19","author":"MM Verbeek","year":"2004","unstructured":"Verbeek MM, Abdo WF, De Jong D, Horstink MW, Kremer BP, Bloem BR. Cerebrospinal fluid Abeta42 levels in multiple system atrophy. Mov Disord. 2004;19:238\u201340. author reply 40-1","journal-title":"Mov Disord"},{"key":"1072_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fneur.2012.00187","volume":"3","author":"R Constantinescu","year":"2013","unstructured":"Constantinescu R, Mondello S. Cerebrospinal fluid biomarker candidates for parkinsonian disorders. Front Neurol. 2013;3:187.","journal-title":"Front Neurol"},{"key":"1072_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.parkreldis.2008.05.001","volume":"15","author":"R Constantinescu","year":"2009","unstructured":"Constantinescu R, Zetterberg H, Holmberg B, Rosengren L. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders. Parkinsonism Relat Disord. 2009;15:205\u201312.","journal-title":"Parkinsonism Relat Disord"},{"key":"1072_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.870130116","volume":"13","author":"B Holmberg","year":"1998","unstructured":"Holmberg B, Rosengren L, Karlsson JE, Johnels B. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord. 1998;13:70\u20137.","journal-title":"Mov Disord"},{"key":"1072_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.23341","volume":"26","author":"MB Aerts","year":"2011","unstructured":"Aerts MB, Esselink RA, Bloem BR, Verbeek MM. Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome. Mov Disord. 2011;26:169\u201373.","journal-title":"Mov Disord"},{"key":"1072_CR22","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord. 2007;22:1901\u201311.","journal-title":"Mov Disord"},{"key":"1072_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"1072_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating scale. Mov Disord. 2012;27:242\u20137.","journal-title":"Mov Disord"},{"key":"1072_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540\u20135.","journal-title":"Sleep"},{"key":"1072_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \"mini-mental state\". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"1072_CR27","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621\u20136.","journal-title":"Neurology"},{"key":"1072_CR28","first-page":"266","volume":"5","author":"TW Robbins","year":"1994","unstructured":"Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5:266\u201381.","journal-title":"Dementia"},{"key":"1072_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427\u201342.","journal-title":"Neurology"},{"key":"1072_CR30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717\u201320.","journal-title":"Neurology"},{"key":"1072_CR31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/clinchem\/44.9.1897","volume":"44","author":"C Brautigam","year":"1998","unstructured":"Brautigam C, Wevers RA, Jansen RJ, Smeitink JA, de Rijk-van Andel JF, Gabreels FJ, et al. Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem. 1998;44:1897\u2013904.","journal-title":"Clin Chem"},{"key":"1072_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneumeth.2007.09.021","volume":"168","author":"WJ van Geel","year":"2008","unstructured":"van Geel WJ, Abdo WF, Melis R, Williams S, Bloem BR, Verbeek MM. A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid. J Neurosci Methods. 2008;168:182\u20135.","journal-title":"J Neurosci Methods"},{"key":"1072_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jim.2004.11.015","volume":"296","author":"WJ Van Geel","year":"2005","unstructured":"Van Geel WJ, Rosengren LE, Verbeek MM. An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid. J Immunol Methods. 2005;296:179\u201385.","journal-title":"J Immunol Methods"},{"key":"1072_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00415-014-7568-4","volume":"262","author":"MB Aerts","year":"2015","unstructured":"Aerts MB, Esselink RA, Abdo WF, Meijer FJ, Drost G, Norgren N, et al. Ancillary investigations to diagnose parkinsonism: a prospective clinical study. J Neurol. 2015;262:346\u201356.","journal-title":"J Neurol"},{"key":"1072_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"1072_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670\u20136.","journal-title":"Neurology"},{"key":"1072_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853\u201364.","journal-title":"Mov Disord"},{"key":"1072_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496\u2013503.","journal-title":"Neurology"},{"key":"1072_CR39","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, Revesz T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19:630\u201340.","journal-title":"Mov Disord"},{"key":"1072_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321.","journal-title":"Stat Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1072-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1072-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1072-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T01:23:03Z","timestamp":1604280183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1072-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1072"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1072-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"3 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical Ethics Committee Arnhem-Nijmegen approved the study. Written informed consent will be obtained from all patients after detailed explanation of the procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}